But results take time, consistency, and a realistic mindset
Wong C, Lee MH, Yaow CYL, Chin YH, Goh XL, Ng CH, et al
In reality, cost is a major consideration for these weight loss medications, says Alyssa Dominguez, MD, an endocrinologist with Keck Medicine of USC
For Research Use Only Not for Human or Veterinary Use Description Additional information For In Vitro Research Use Only Not for Human or Veterinary Use Molecular Weight 711.9 Daltons Structure 5 AA Selective GHSR-1a Agonist Branded Packaging IDUN Custom labelled vial & box COA Per Lot 3rd Party Freedom Diagnostics, ships in box Identity LC-MS Mass-confirmed lot-by-lot Chemical & Physical Specifications About Ipamorelin Ipamorelin (H-Aib-His-D-2-Nal-D-Phe-Lys-NH) is a synthetic pentapeptide first reported by Raun and colleagues (1998) at Novo Nordisk A/S under the internal designation NNC 26-0161
No large human safety trial exists
Presented for research literature review only Kochhar S et al